HIKALNSEHikal Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 15 May · 15:46 IST

Hikal Limited has informed the Exchange about Copy of Newspaper Publication of Audited standalone and consolidated financial results of the Company for the Quarter and year ended March 31, 2025.

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Hikal Limited has informed the stock exchanges (BSE and NSE) that it has published its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025, in newspapers as required by SEBI rules. The advertisements appeared in Business Standard (English) and Mumbai Lakshadeep (Marathi) on May 15, 2025. The intimation is filed under Regulation 30 read with Regulation 47 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The filing was signed by Rajasekhar Reddy, Company Secretary and Compliance Officer. The full results are also available on the company's website (www.hikal.com). No specific financial figures from Hikal's results are included in this filing — it is a routine compliance disclosure confirming the newspaper publication.

Likely market impact

This is a routine regulatory compliance filing with no direct material impact on the stock price. It simply confirms that the company's Q4 and full-year FY25 results, which would have been approved and disclosed earlier, have now been published in newspapers as required by SEBI. Shareholders looking for the actual numbers should refer to the company's website or the earlier detailed results filing.